Zebra Medical Vision names new CEO

Zebra Medical Vision has appointed Ohad Arazi as the company’s new CEO, a move that will be effective beginning March 1. Arazi has previously worked for McKesson Technology Solutions, Change Healthcare and TELUS Health.

“Every CEO dreams of being able to drive the evolution of a company from such a position of material strength,” Arazi said in a prepared statement. “As we expand our footprint in North America, the breadth of Zebra-Med’s products and compelling regulatory advantage will allow us to scale extraordinarily fast. I am thankful for the opportunity to lead one of the most exciting teams in healthcare today, and to leverage artificial intelligence to affect change for the medical imaging industry worldwide.”

Arazi is succeeding Eyal Gura, the company’s co-founder, in this position. Gura will remain in place as Zebra-Med’s chairman of the board.

 “Ohad Arazi's appointment is a clear reflection of the strong vector the Zebra Medical Vision team has created, as we’re ready to take on the future after another strong year of product innovation, unique regulatory progress, and customer successes,” Gura said in the same statement. “Zebra-Med is poised for major expansion in the medical imaging domain, and we're confident that Ohad's unique experience in turning innovative technologies into scalable and impactful products will drive significant growth for us.”

Other recent AI in Healthcare coverage of Zebra-Med can be read here and here.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”